Spun out of University of Côte d’Azur and Inserm, InnoSkel expects to fund clinical work to address a form of skeletal dysplasia that causes dwarfism.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Koch Industries took part in a series B round for the identity management platform developer that increased its total funding to $105m since its launch earlier this year.

Sky, GMG Ventures and BDMI participated in a $10.6m round for Papercup as it continues to enhance its content translation technology.

Greenlight Re-backed travel insurance startup Battleface has lured Drive Capital for a series A round set to drive its growth plans.

Toyota AI Ventures returned for a series A round that will be used to strengthen technology that helps create datasets for autonomous vehicle models.

University of Oxford joined Oxford Sciences Innovation to back neuromuscular disease therapy spinout PepGen, which will move its base to the US.

PrinterPrezz enticed the Berkeley Catalyst Fund in a series A round that will help expand its medical device 3D printing business.

Solvay Ventures was among the participants in a series A round for 3D-printed medical technology developer PrinterPrezz.

Alexandria Venture Investments has helped RNA drug developer Remix Therapeutics launch with seed and series A funding.